HEADER TRANSCRIPTION 25-JUN-18 6A5Z TITLE CRYSTAL STRUCTURE OF HUMAN FXR/RXR-LBD HETERODIMER BOUND TO HNC180 AND TITLE 2 9CRA AND SRC1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BILE ACID RECEPTOR; COMPND 3 CHAIN: A, H; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: FARNESOID X-ACTIVATED RECEPTOR,FARNESOL RECEPTOR HRR-1, COMPND 6 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4,RETINOID X RECEPTOR- COMPND 7 INTERACTING PROTEIN 14,RXR-INTERACTING PROTEIN 14; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 12 CHAIN: D, L; COMPND 13 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 14 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 2 GROUP B MEMBER 1,RETINOID X COMPND 15 RECEPTOR ALPHA; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 19 CHAIN: E, F, G, I; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H4, BAR, FXR, HRR1, RIP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: RXRA, NR2B1; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: ROSETTA2(DE3); SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR HETERODIMER, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR N.WANG,J.LIU REVDAT 4 27-MAR-24 6A5Z 1 REMARK REVDAT 3 05-DEC-18 6A5Z 1 JRNL REVDAT 2 17-OCT-18 6A5Z 1 COMPND JRNL REVDAT 1 10-OCT-18 6A5Z 0 JRNL AUTH N.WANG,Q.ZOU,J.XU,J.ZHANG,J.LIU JRNL TITL LIGAND BINDING AND HETERODIMERIZATION WITH RETINOID X JRNL TITL 2 RECEPTOR ALPHA (RXR ALPHA ) INDUCE FARNESOID X RECEPTOR JRNL TITL 3 (FXR) CONFORMATIONAL CHANGES AFFECTING COACTIVATOR BINDING JRNL REF J. BIOL. CHEM. V. 293 18180 2018 JRNL REFN ESSN 1083-351X JRNL PMID 30275017 JRNL DOI 10.1074/JBC.RA118.004652 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 19737 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1069 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1455 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7371 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.65000 REMARK 3 B22 (A**2) : 1.53000 REMARK 3 B33 (A**2) : -3.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.527 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.450 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.785 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.910 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.869 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7655 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7294 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10340 ; 1.526 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16934 ; 1.035 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 898 ; 5.847 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 358 ;39.373 ;24.302 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1414 ;18.967 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;18.241 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1169 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8227 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1479 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6A5Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1300008203. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9778 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 89.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.18200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.57500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM IODIDE, 20% W/V REMARK 280 POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.76500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.12000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.06500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.12000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.76500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.06500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, G, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 339 REMARK 465 LEU A 340 REMARK 465 PRO A 341 REMARK 465 SER A 342 REMARK 465 GLY A 343 REMARK 465 HIS A 344 REMARK 465 ASP A 458 REMARK 465 HIS A 459 REMARK 465 GLN A 472 REMARK 465 SER D 225 REMARK 465 ALA D 226 REMARK 465 ASN D 227 REMARK 465 LYS D 245 REMARK 465 THR D 246 REMARK 465 GLU D 247 REMARK 465 THR D 248 REMARK 465 TYR D 249 REMARK 465 VAL D 250 REMARK 465 GLU D 251 REMARK 465 ALA D 252 REMARK 465 ASN D 253 REMARK 465 MET D 254 REMARK 465 GLY D 255 REMARK 465 LEU D 256 REMARK 465 ASN D 257 REMARK 465 PRO D 258 REMARK 465 SER D 259 REMARK 465 SER D 260 REMARK 465 PRO D 261 REMARK 465 ALA D 457 REMARK 465 PRO D 458 REMARK 465 HIS D 459 REMARK 465 GLN D 460 REMARK 465 MET D 461 REMARK 465 THR D 462 REMARK 465 LEU H 340 REMARK 465 PRO H 341 REMARK 465 HIS H 459 REMARK 465 VAL H 471 REMARK 465 GLN H 472 REMARK 465 SER L 225 REMARK 465 ALA L 226 REMARK 465 ASN L 227 REMARK 465 GLU L 228 REMARK 465 ASP L 229 REMARK 465 PRO L 244 REMARK 465 LYS L 245 REMARK 465 THR L 246 REMARK 465 GLU L 247 REMARK 465 THR L 248 REMARK 465 TYR L 249 REMARK 465 VAL L 250 REMARK 465 GLU L 251 REMARK 465 ALA L 252 REMARK 465 ASN L 253 REMARK 465 MET L 254 REMARK 465 GLY L 255 REMARK 465 LEU L 256 REMARK 465 ASN L 257 REMARK 465 PRO L 258 REMARK 465 SER L 259 REMARK 465 SER L 260 REMARK 465 PRO L 261 REMARK 465 ASN L 262 REMARK 465 ALA L 457 REMARK 465 PRO L 458 REMARK 465 HIS L 459 REMARK 465 GLN L 460 REMARK 465 MET L 461 REMARK 465 THR L 462 REMARK 465 SER E 759 REMARK 465 GLU F 628 REMARK 465 ARG F 629 REMARK 465 SER F 641 REMARK 465 PRO F 642 REMARK 465 SER F 643 REMARK 465 GLU G 744 REMARK 465 GLY G 756 REMARK 465 SER G 757 REMARK 465 PRO G 758 REMARK 465 SER G 759 REMARK 465 GLU I 628 REMARK 465 ARG I 629 REMARK 465 GLU I 639 REMARK 465 GLY I 640 REMARK 465 SER I 641 REMARK 465 PRO I 642 REMARK 465 SER I 643 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 244 CG CD OE1 OE2 REMARK 470 LYS A 376 CG CD CE NZ REMARK 470 GLU H 244 CG CD OE1 OE2 REMARK 470 LYS H 376 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 272 49.26 -91.86 REMARK 500 PHE A 278 69.54 -119.08 REMARK 500 ASN A 354 69.03 -103.77 REMARK 500 LEU A 391 52.95 -90.61 REMARK 500 PHE A 461 -104.73 -108.82 REMARK 500 ASP A 470 142.43 80.13 REMARK 500 HIS D 288 -3.95 81.20 REMARK 500 THR D 445 123.64 149.18 REMARK 500 LYS H 272 35.28 -87.58 REMARK 500 LEU H 274 52.61 -111.24 REMARK 500 LYS H 275 -52.07 -151.25 REMARK 500 PHE H 278 69.47 -117.58 REMARK 500 ASN H 354 71.04 -103.68 REMARK 500 LEU H 391 52.89 -90.47 REMARK 500 ASN H 457 37.84 -160.41 REMARK 500 PHE H 461 -104.95 -108.43 REMARK 500 TRP H 469 -166.40 -112.63 REMARK 500 HIS L 288 -3.16 80.65 REMARK 500 THR L 445 124.18 147.62 REMARK 500 HIS E 746 55.13 -112.36 REMARK 500 GLN E 754 73.74 -109.37 REMARK 500 GLU E 755 -51.24 -151.37 REMARK 500 SER E 757 162.06 -44.22 REMARK 500 GLU F 639 32.52 -151.54 REMARK 500 HIS G 746 59.44 -118.77 REMARK 500 GLN G 754 72.74 -109.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9R3 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9CR D 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9R3 H 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9CR L 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6A5Y RELATED DB: PDB DBREF 6A5Z A 244 472 UNP Q96RI1 NR1H4_HUMAN 258 486 DBREF 6A5Z D 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 6A5Z H 244 472 UNP Q96RI1 NR1H4_HUMAN 258 486 DBREF 6A5Z L 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 6A5Z E 744 759 UNP B5MCN7 B5MCN7_HUMAN 534 549 DBREF 6A5Z F 628 643 UNP B5MCN7 B5MCN7_HUMAN 534 549 DBREF 6A5Z G 744 759 UNP B5MCN7 B5MCN7_HUMAN 534 549 DBREF 6A5Z I 628 643 UNP B5MCN7 B5MCN7_HUMAN 534 549 SEQADV 6A5Z GLU A 432 UNP Q96RI1 CYS 446 ENGINEERED MUTATION SEQADV 6A5Z GLU A 466 UNP Q96RI1 CYS 480 ENGINEERED MUTATION SEQADV 6A5Z GLU H 432 UNP Q96RI1 CYS 446 ENGINEERED MUTATION SEQADV 6A5Z GLU H 466 UNP Q96RI1 CYS 480 ENGINEERED MUTATION SEQRES 1 A 229 GLU LEU THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE SEQRES 2 A 229 MET ASP SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE SEQRES 3 A 229 THR ASN LYS ILE LEU LYS GLU GLU PHE SER ALA GLU GLU SEQRES 4 A 229 ASN PHE LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL SEQRES 5 A 229 GLN VAL LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE SEQRES 6 A 229 GLN THR LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS SEQRES 7 A 229 GLY SER ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU SEQRES 8 A 229 ILE PHE ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU SEQRES 9 A 229 LEU GLU GLU ARG ILE ARG ASN SER GLY ILE SER ASP GLU SEQRES 10 A 229 TYR ILE THR PRO MET PHE SER PHE TYR LYS SER ILE GLY SEQRES 11 A 229 GLU LEU LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR SEQRES 12 A 229 ALA ILE VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS SEQRES 13 A 229 ASP ARG GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU SEQRES 14 A 229 ASP VAL LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU SEQRES 15 A 229 ASN PRO GLN HIS PHE ALA GLU LEU LEU GLY ARG LEU THR SEQRES 16 A 229 GLU LEU ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU SEQRES 17 A 229 MET SER TRP ARG VAL ASN ASP HIS LYS PHE THR PRO LEU SEQRES 18 A 229 LEU GLU GLU ILE TRP ASP VAL GLN SEQRES 1 D 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 D 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 D 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 D 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 D 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 D 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 D 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 D 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 D 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 D 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 D 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 D 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 D 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 D 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 D 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 D 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 D 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 D 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 D 238 HIS GLN MET THR SEQRES 1 H 229 GLU LEU THR PRO ASP GLN GLN THR LEU LEU HIS PHE ILE SEQRES 2 H 229 MET ASP SER TYR ASN LYS GLN ARG MET PRO GLN GLU ILE SEQRES 3 H 229 THR ASN LYS ILE LEU LYS GLU GLU PHE SER ALA GLU GLU SEQRES 4 H 229 ASN PHE LEU ILE LEU THR GLU MET ALA THR ASN HIS VAL SEQRES 5 H 229 GLN VAL LEU VAL GLU PHE THR LYS LYS LEU PRO GLY PHE SEQRES 6 H 229 GLN THR LEU ASP HIS GLU ASP GLN ILE ALA LEU LEU LYS SEQRES 7 H 229 GLY SER ALA VAL GLU ALA MET PHE LEU ARG SER ALA GLU SEQRES 8 H 229 ILE PHE ASN LYS LYS LEU PRO SER GLY HIS SER ASP LEU SEQRES 9 H 229 LEU GLU GLU ARG ILE ARG ASN SER GLY ILE SER ASP GLU SEQRES 10 H 229 TYR ILE THR PRO MET PHE SER PHE TYR LYS SER ILE GLY SEQRES 11 H 229 GLU LEU LYS MET THR GLN GLU GLU TYR ALA LEU LEU THR SEQRES 12 H 229 ALA ILE VAL ILE LEU SER PRO ASP ARG GLN TYR ILE LYS SEQRES 13 H 229 ASP ARG GLU ALA VAL GLU LYS LEU GLN GLU PRO LEU LEU SEQRES 14 H 229 ASP VAL LEU GLN LYS LEU CYS LYS ILE HIS GLN PRO GLU SEQRES 15 H 229 ASN PRO GLN HIS PHE ALA GLU LEU LEU GLY ARG LEU THR SEQRES 16 H 229 GLU LEU ARG THR PHE ASN HIS HIS HIS ALA GLU MET LEU SEQRES 17 H 229 MET SER TRP ARG VAL ASN ASP HIS LYS PHE THR PRO LEU SEQRES 18 H 229 LEU GLU GLU ILE TRP ASP VAL GLN SEQRES 1 L 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 L 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 L 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 L 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 L 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 L 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 L 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 L 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 L 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 L 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 L 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 L 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 L 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 L 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 L 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 L 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 L 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 L 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 L 238 HIS GLN MET THR SEQRES 1 E 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 E 16 SER PRO SER SEQRES 1 F 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 F 16 SER PRO SER SEQRES 1 G 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 G 16 SER PRO SER SEQRES 1 I 16 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SEQRES 2 I 16 SER PRO SER HET 9R3 A 501 39 HET 9CR D 501 22 HET 9R3 H 501 39 HET 9CR L 501 22 HETNAM 9R3 2-[(1R,5S)-9-[[3-[2,6-BIS(CHLORANYL)PHENYL]-5- HETNAM 2 9R3 CYCLOPROPYL-1,2-OXAZOL-4-YL]METHOXY]-3- HETNAM 3 9R3 AZABICYCLO[3.3.1]NONAN-3-YL]-1,3-BENZOTHIAZOLE-6- HETNAM 4 9R3 CARBOXYLIC ACID HETNAM 9CR (9CIS)-RETINOIC ACID FORMUL 9 9R3 2(C29 H27 CL2 N3 O4 S) FORMUL 10 9CR 2(C20 H28 O2) FORMUL 13 HOH *17(H2 O) HELIX 1 AA1 THR A 246 LYS A 262 1 17 HELIX 2 AA2 PRO A 266 ASN A 271 1 6 HELIX 3 AA3 SER A 279 LYS A 304 1 26 HELIX 4 AA4 GLY A 307 LEU A 311 5 5 HELIX 5 AA5 ASP A 312 ASN A 337 1 26 HELIX 6 AA6 ASP A 346 ASN A 354 1 9 HELIX 7 AA7 SER A 358 GLU A 360 5 3 HELIX 8 AA8 TYR A 361 GLU A 374 1 14 HELIX 9 AA9 THR A 378 LEU A 391 1 14 HELIX 10 AB1 ASP A 400 GLN A 423 1 24 HELIX 11 AB2 GLN A 428 TRP A 454 1 27 HELIX 12 AB3 THR A 462 ASP A 470 1 9 HELIX 13 AB4 PRO D 231 VAL D 242 1 12 HELIX 14 AB5 ASP D 263 ARG D 285 1 23 HELIX 15 AB6 PRO D 293 SER D 317 1 25 HELIX 16 AB7 ARG D 334 ALA D 340 1 7 HELIX 17 AB8 VAL D 342 LEU D 353 1 12 HELIX 18 AB9 LEU D 353 MET D 360 1 8 HELIX 19 AC1 ASP D 363 PHE D 376 1 14 HELIX 20 AC2 ASN D 385 TYR D 408 1 24 HELIX 21 AC3 GLY D 413 LEU D 420 1 8 HELIX 22 AC4 LEU D 420 GLY D 443 1 24 HELIX 23 AC5 ASP D 448 LEU D 455 1 8 HELIX 24 AC6 THR H 246 LYS H 262 1 17 HELIX 25 AC7 PRO H 266 ASN H 271 1 6 HELIX 26 AC8 SER H 279 LYS H 304 1 26 HELIX 27 AC9 GLY H 307 LEU H 311 5 5 HELIX 28 AD1 ASP H 312 ASN H 337 1 26 HELIX 29 AD2 GLY H 343 ASN H 354 1 12 HELIX 30 AD3 SER H 358 GLU H 360 5 3 HELIX 31 AD4 TYR H 361 GLU H 374 1 14 HELIX 32 AD5 THR H 378 LEU H 391 1 14 HELIX 33 AD6 ASP H 400 GLN H 423 1 24 HELIX 34 AD7 GLN H 428 TRP H 454 1 27 HELIX 35 AD8 THR H 462 TRP H 469 1 8 HELIX 36 AD9 PRO L 231 VAL L 242 1 12 HELIX 37 AE1 PRO L 264 ARG L 285 1 22 HELIX 38 AE2 PRO L 293 SER L 317 1 25 HELIX 39 AE3 ARG L 334 ALA L 340 1 7 HELIX 40 AE4 VAL L 342 LEU L 353 1 12 HELIX 41 AE5 LEU L 353 MET L 360 1 8 HELIX 42 AE6 ASP L 363 PHE L 376 1 14 HELIX 43 AE7 ASN L 385 TYR L 408 1 24 HELIX 44 AE8 GLY L 413 LEU L 420 1 8 HELIX 45 AE9 LEU L 420 GLY L 443 1 24 HELIX 46 AF1 ASP L 448 LEU L 455 1 8 HELIX 47 AF2 HIS E 746 GLN E 754 1 9 HELIX 48 AF3 LYS F 631 GLN F 638 1 8 HELIX 49 AF4 HIS G 746 GLN G 754 1 9 HELIX 50 AF5 LYS I 631 GLN I 638 1 8 SHEET 1 AA1 2 GLY D 323 LEU D 325 0 SHEET 2 AA1 2 HIS D 331 HIS D 333 -1 O VAL D 332 N ILE D 324 SHEET 1 AA2 2 GLY L 323 LEU L 325 0 SHEET 2 AA2 2 HIS L 331 HIS L 333 -1 O VAL L 332 N ILE L 324 SITE 1 AC1 11 MET A 290 MET A 328 PHE A 329 ARG A 331 SITE 2 AC1 11 SER A 332 ILE A 335 TYR A 369 HIS A 447 SITE 3 AC1 11 MET A 450 TRP A 454 PHE A 461 SITE 1 AC2 8 ILE D 268 ALA D 271 ALA D 272 PHE D 313 SITE 2 AC2 8 ARG D 316 LEU D 326 ALA D 327 CYS D 432 SITE 1 AC3 13 MET H 265 MET H 290 MET H 328 PHE H 329 SITE 2 AC3 13 SER H 332 ILE H 335 LEU H 348 TYR H 369 SITE 3 AC3 13 HIS H 447 TRP H 454 PHE H 461 LEU H 465 SITE 4 AC3 13 TRP H 469 SITE 1 AC4 9 ILE L 268 ALA L 271 ALA L 272 GLN L 275 SITE 2 AC4 9 PHE L 313 ARG L 316 LEU L 326 ALA L 327 SITE 3 AC4 9 ILE L 345 CRYST1 89.530 96.130 114.240 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011169 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008754 0.00000